Cytokines as Plasma Markers of Abdominal Aortic Aneurysm
-
Vladislav Třeška
Abstract
The pathogenesis of abdominal aortic aneurysms (AAA) is a complex process in which atherosclerosis and inflammation play a leading role. Cytokines are important mediators of both processes. The aim of our study was to determine whether plasma levels of cytokines which are most involved in AAA pathogenesis can be used as endogenous markers of AAA development, and thus to facilitate the decision on surgical intervention in cases when this is clinically unclear (e.g. small AAA).
In the prospective study a total of 90 patients with AAA were examined. These patients were divided into the following groups according to symptoms and AAA diameter: symptomatic AAAs, including ruptures (n=16); asymptomatic AAAs (n=74); AAAs with a diameter of up to 5 cm (n=30), AAAs of 5–8 cm (n=38), and AAAs with a diameter over 8 cm (n=22). The average age of the patients was 70.7 (56–82) years. The male to female ratio was 4:1 (71:19). A control group consisted of 30 healthy individuals of similar age and sex presentation with no manifestation of atherosclerosis. Plasma levels of cytokines were assessed in venous blood by means of radio- or enzymo-immunoassay. Statistical processing of the results was conducted with ANOVA and Wilcoxon tests with Spearman correlation, where p<0.05 was considered to be statistically significant.
Plasma concentrations of cytokines were significantly higher in AAA patients than in healthy individuals. In AAA patients the tumour necrosis factor-α (TNF-α) and interleukin (IL-8) levels were low in large and in symptomatic AAAs. IL-6 levels were increased with increasing AAA diameter and symptoms. IL-8 levels (p<0.05) showed a statistically significant correlation with the diameter, and TNF-α (p<0.05) with the symptoms of AAA. IL-1β, IL-2 and IL-6 did not show any significant changes with different AAA diameter or symptomatology.
In Conclusion: IL-8 and TNF-α can be used as endogenous markers of the process of AAA development, in deciding for either surgical or endovascular treatment of patients when the clinical indication is not entirely clear.
Copyright © 2000 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- European Meeting on Biomarkers of Organ Damage and Dysfunction Selected Papers from the Meeting Held in Cambridge, UK April 3rd-7th, 2000
- Kidney Retrieval Conditions Influence Damage to Renal Medulla: Evaluation by Proton Nuclear Magnetic Resonance (NMR) Spectroscopy
- Citrate, Acetate and Renal Medullary Osmolyte Excretion in Urine as Predictor of Renal Changes after Cold Ischaemia and Transplantation
- Comparison of Proteolytic Enzymes and Glutathione S-Transferase Levels in Non-Heart-Beating Donors' (NHBD) Kidney Perfusates
- Assessment of Non-Heart-Beating Donor (NHBD) Kidneys for Viability on Machine Perfusion
- Low Levels of Urinary Albumin Excretion Are Associated with Cardiovascular Risk Factors in the General Population
- Evaluation of a Fully Automated Assay to Measure C-Telopeptide of Type I Collagen in Serum
- Bone Turnover Markers and Estradiol Level in Postmenopausal Women
- External Quality Assessment of Bone Metabolism Marker Assays. Initial Experiences in a UK NEQAS Programme
- The Monoethylglycinexylidide (MEGX) Test as a Marker of Hepatic Dysfunction in Septic Patients with Pneumonia
- Transforming Growth Factor-β1 as a Surrogate Marker of Hepatic Dysfunction in Chronic Liver Diseases
- A New Approach to the Evaluation of Liver Graft Function by Nuclear Magnetic Resonance Spectroscopy. A Comparative Study between Euro-Collins and University of Wisconsin Solutions
- Metallothionein and Heat Shock Protein Expression during Acute Liver Injury and Regeneration in Rats
- Biochemical Evaluation of Patients with Acute Pancreatitis
- Screening for Acute Myocardial Injury: Creatine Kinase Is Comparable to Myoglobin
- Different Time Frames for the Occurrence of Elevated Levels of Cardiac Troponin T and C-Reactive Protein in Patients with Acute Myocardial Infarction
- Determination of Decision Limits for ACS:Systems Cardiac Troponin I
- Stability of Cardiac Troponins and CK-MB Mass Isoenzyme
- Cytokines as Plasma Markers of Abdominal Aortic Aneurysm
- The Early Fall in Levels of S-100 β in Traumatic Brain Injury
- Protein S-100β in Brain and Serum after Deep Hypothermic Circulatory Arrest in Rabbits: Relationship to Perivascular Astrocytic Swelling
- The Effect of Continuous Treatment with Sodium Nitroprusside on the Serum Kinetics of the Brain Marker Protein S-100β in Neonates Undergoing Corrective Cardiac Surgery by Means of Hypothermic Cardiopulmonary Bypass
- Differentiated Therapy with Prostaglandin E1 (Alprostadil) after Orthotopic Liver Transplantation: the Usefulness of Procalcitonin (PCT) and Hepatic Artery Resistive Index (RI) for the Evaluation of Early Graft Function and Clinical Course
- The Postoperative Course of γ-Glutamyl Transpeptidase – a Marker of Cytomegalovirus (CMV) Replication Risk?
- TNF-α and Its Receptors Mediate Graft Rejection and Loss after Liver Transplantation
- Impact of Ig-Therasorb® Immunoapheresis on Stability of Xenogeneic Ex Vivo Porcine Liver Perfusion – Value of Aminotransferases and Flow Rates for the Assessment of Metabolic Graft Viability
- The Effect of Human Organ Preservation and Albumin Flush Solution on In Vitro Cell Metabolic Activity
- An Ex Vivo Model of Tolerance vs. Rejection: Comparison of Different Signal Transducers and Activators of Transcription, STAT1, STAT4, STAT5 and STAT6
- Detection of Cytomegalovirus (CMV) Antigens in Kidney Biopsies and Transplant Nephrectomies as a Marker for Renal Graft Dysfunction
- Comparison of Five Cyclosporin Immunoassays with HPLC
- In Vitro Pentamer Formation as a Biomarker of Tacrolimus-Related Immunosuppressive Activity after Liver Transplantation
- Pharmacodynamic Monitoring of Mycophenolate Mofetil
Articles in the same Issue
- European Meeting on Biomarkers of Organ Damage and Dysfunction Selected Papers from the Meeting Held in Cambridge, UK April 3rd-7th, 2000
- Kidney Retrieval Conditions Influence Damage to Renal Medulla: Evaluation by Proton Nuclear Magnetic Resonance (NMR) Spectroscopy
- Citrate, Acetate and Renal Medullary Osmolyte Excretion in Urine as Predictor of Renal Changes after Cold Ischaemia and Transplantation
- Comparison of Proteolytic Enzymes and Glutathione S-Transferase Levels in Non-Heart-Beating Donors' (NHBD) Kidney Perfusates
- Assessment of Non-Heart-Beating Donor (NHBD) Kidneys for Viability on Machine Perfusion
- Low Levels of Urinary Albumin Excretion Are Associated with Cardiovascular Risk Factors in the General Population
- Evaluation of a Fully Automated Assay to Measure C-Telopeptide of Type I Collagen in Serum
- Bone Turnover Markers and Estradiol Level in Postmenopausal Women
- External Quality Assessment of Bone Metabolism Marker Assays. Initial Experiences in a UK NEQAS Programme
- The Monoethylglycinexylidide (MEGX) Test as a Marker of Hepatic Dysfunction in Septic Patients with Pneumonia
- Transforming Growth Factor-β1 as a Surrogate Marker of Hepatic Dysfunction in Chronic Liver Diseases
- A New Approach to the Evaluation of Liver Graft Function by Nuclear Magnetic Resonance Spectroscopy. A Comparative Study between Euro-Collins and University of Wisconsin Solutions
- Metallothionein and Heat Shock Protein Expression during Acute Liver Injury and Regeneration in Rats
- Biochemical Evaluation of Patients with Acute Pancreatitis
- Screening for Acute Myocardial Injury: Creatine Kinase Is Comparable to Myoglobin
- Different Time Frames for the Occurrence of Elevated Levels of Cardiac Troponin T and C-Reactive Protein in Patients with Acute Myocardial Infarction
- Determination of Decision Limits for ACS:Systems Cardiac Troponin I
- Stability of Cardiac Troponins and CK-MB Mass Isoenzyme
- Cytokines as Plasma Markers of Abdominal Aortic Aneurysm
- The Early Fall in Levels of S-100 β in Traumatic Brain Injury
- Protein S-100β in Brain and Serum after Deep Hypothermic Circulatory Arrest in Rabbits: Relationship to Perivascular Astrocytic Swelling
- The Effect of Continuous Treatment with Sodium Nitroprusside on the Serum Kinetics of the Brain Marker Protein S-100β in Neonates Undergoing Corrective Cardiac Surgery by Means of Hypothermic Cardiopulmonary Bypass
- Differentiated Therapy with Prostaglandin E1 (Alprostadil) after Orthotopic Liver Transplantation: the Usefulness of Procalcitonin (PCT) and Hepatic Artery Resistive Index (RI) for the Evaluation of Early Graft Function and Clinical Course
- The Postoperative Course of γ-Glutamyl Transpeptidase – a Marker of Cytomegalovirus (CMV) Replication Risk?
- TNF-α and Its Receptors Mediate Graft Rejection and Loss after Liver Transplantation
- Impact of Ig-Therasorb® Immunoapheresis on Stability of Xenogeneic Ex Vivo Porcine Liver Perfusion – Value of Aminotransferases and Flow Rates for the Assessment of Metabolic Graft Viability
- The Effect of Human Organ Preservation and Albumin Flush Solution on In Vitro Cell Metabolic Activity
- An Ex Vivo Model of Tolerance vs. Rejection: Comparison of Different Signal Transducers and Activators of Transcription, STAT1, STAT4, STAT5 and STAT6
- Detection of Cytomegalovirus (CMV) Antigens in Kidney Biopsies and Transplant Nephrectomies as a Marker for Renal Graft Dysfunction
- Comparison of Five Cyclosporin Immunoassays with HPLC
- In Vitro Pentamer Formation as a Biomarker of Tacrolimus-Related Immunosuppressive Activity after Liver Transplantation
- Pharmacodynamic Monitoring of Mycophenolate Mofetil
